Cite
HARVARD Citation
Flint, A. et al. (n.d.). The once‐daily human GLP‐1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short‐term treatment. Diabetes, obesity & metabolism. 15 (10), pp. 958-962. [Online].